Clinical trial
Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars
NCT00469235 · Renovo, Industry · Completed
Key facts
| NCT number | NCT00469235 |
|---|---|
| Title | Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars |
| Official title | A Single-centre, Double Blind, Randomised, Rising Dose Tolerance Study to Investigate the Safety of Juvista When Administered Following Excision of Ear Lobe Keloids. |
| Lead sponsor | Renovo, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Keloid |
| Intervention type | Drug |
| Interventions | Avotermin |
| Enrollment | 20 |
| Start date | Jun 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | May 1, 2009 |
| First posted | May 4, 2007 |
| Last update posted | Sep 16, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: